It’s the only injectable buprenorphine that presents both equally weekly and monthly dosing choices. BRIXADI is indicated for the treatment of average to severe opioid use dysfunction (OUD) in clients who've initiated treatment with an individual dose of a transmucosal buprenorphine products or who are now getting dealt with https://medication-that-helps-her45554.xzblogs.com/71585899/getting-my-drug-given-to-recovering-heroin-addicts-to-work